On the recordDecember 12, 2019
I thank the ranking member for his thoughtful comments and his thoughts about what I think is clearly an unmet need and one we need to continue to invest in, so I thank him for his leadership, too, sir. Before I finish, let me just say that I urge all my colleagues to vote ``yes'' on this amendment, because we need to keep making those investments to keep our leadership as a country when it comes to R&D innovation. It is one of the reasons why our country is so great and why so many lives have been saved and so many families and children helped. We need to make sure that we get drug prices down overall, which is why this legislation is so important, to make sure we have competition, more development of generics in the marketplace and, of course, overall the best quality healthcare in the world. It is critical for our country. Mr. Chairman, I yield back the balance of my time.





